- Home
- CATX vs IGR Comparison
CATX vs IGR Comparison
Compare CATX & IGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- IGR
- Stock Information
- Founded
- CATX 1983
- IGR 2004
- Country
- CATX United States
- IGR United States
- Employees
- CATX N/A
- IGR N/A
- Industry
- CATX Medical/Dental Instruments
- IGR Finance Companies
- Sector
- CATX Health Care
- IGR Finance
- Exchange
- CATX Nasdaq
- IGR Nasdaq
- Market Cap
- CATX 782.7M
- IGR 721.1M
- IPO Year
- CATX N/A
- IGR N/A
- Fundamental
- Price
- CATX $2.78
- IGR $5.22
- Analyst Decision
- CATX Strong Buy
- IGR
- Analyst Count
- CATX 9
- IGR 0
- Target Price
- CATX $17.25
- IGR N/A
- AVG Volume (30 Days)
- CATX 724.0K
- IGR 747.7K
- Earning Date
- CATX 03-04-2025
- IGR 01-01-0001
- Dividend Yield
- CATX N/A
- IGR 13.93%
- EPS Growth
- CATX N/A
- IGR N/A
- EPS
- CATX N/A
- IGR N/A
- Revenue
- CATX $1,557,000.00
- IGR N/A
- Revenue This Year
- CATX N/A
- IGR N/A
- Revenue Next Year
- CATX N/A
- IGR N/A
- P/E Ratio
- CATX N/A
- IGR N/A
- Revenue Growth
- CATX N/A
- IGR N/A
- 52 Week Low
- CATX $2.70
- IGR $3.88
- 52 Week High
- CATX $19.10
- IGR $5.70
- Technical
- Relative Strength Index (RSI)
- CATX 32.67
- IGR 49.29
- Support Level
- CATX $2.91
- IGR $5.23
- Resistance Level
- CATX $3.21
- IGR $5.36
- Average True Range (ATR)
- CATX 0.20
- IGR 0.07
- MACD
- CATX -0.03
- IGR -0.00
- Stochastic Oscillator
- CATX 1.75
- IGR 46.30
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
About IGR CBRE Global Real Estate Income Fund of Beneficial Interest
CBRE Clarion Global Real Estate Income Fund is the United States based diversified, closed-end management investment company. Its objective is high current income and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities located mainly in the developed markets of North America, Europe, Australia, and Asia. Its portfolio of investments consists of different sectors such as diversified, retail, industrial, residential, hotels, healthcare, and other sectors.